Alzheimer's disease
Hypothesis labeled education on Alzheimer's disease within Mark Egly Foundation neurological research pages.
Research status: Investigational / hypothesis
Research hypothesis, not medical advice
The connections described on this page come from Mark Egly's patent filing and ongoing research. They are not established medical facts. Always work with your physician for diagnosis and treatment.
Research hypothesis. The connection between Alzheimer's disease and Alpha-1 Antitrypsin is described in Mark Egly's 2020 patent filing. This is not established medical fact and is not medical advice. Always talk with your doctor about your own health.
What is Alzheimer's disease?
Alzheimer's disease is a progressive neurological condition that affects memory and thinking. Diagnosis and treatment belong with neurology and geriatric specialists. The Mark Egly Foundation does not replace dementia care.
Why this page exists
Alzheimer's disease is one of the highest volume health searches in the world. Very little public content connects Alzheimer's topics to AATD. We publish hypothesis labeled education so families can explore research questions without confusing them for proven therapy.
Research framing
The patent discusses inflammation, neutrophil elastase, and serine protease biology in Alzheimer's related literature and proposes that AAT related pathways may matter. Those claims are investigational. Continue evidence based neurological care.
Start with established AATD education
- What is Alpha-1 Antitrypsin Deficiency
- AATD and neurological conditions
- Parkinson's disease
- Multiple sclerosis
- ALS
What you can do
- Follow your neurology team's plan.
- Ask about AAT testing only when lung or liver findings or family history raise the question.
- Read the patent overview.
- Support research.
Sources and references
References checked July 26, 2026
- Alpha-1 antitrypsin deficiency (MedlinePlus Genetics (NIH))Research status: Established clinical knowledge
- American Thoracic Society / European Respiratory Society statements on lung disease (locate current AATD guidance) (American Thoracic Society)Research status: Established clinical knowledgeUse the current ATS/ERS AATD statements applicable to your practice.
- Method of Preventing and/or Treating a Plurality of Diseases (Mark Egly patent disclosure summary) (Mark Egly Foundation patent overview)Research status: Investigational / hypothesisPrimary source for Mark Egly research hypotheses. Not peer-reviewed clinical evidence. Confirm USPTO application number with counsel before citing externally.
Educational content only. Not a diagnosis or treatment plan. Work with your clinician for personal medical decisions.